Team Barcelona


Our study group is the result of a collaborative effort between two specialized teams: gastroenterologists focused on colorectal cancer prevention in Lynch syndrome and other high-risk hereditary cancer syndromes, and immunologists with extensive expertise in immune-related cancer prevention strategies We are currently leading a phase I clinical trial based on autologous dendritic cells loaded with frameshift-derived neopeptides for cancer prevention in individuals with Lynch syndrome.


